why choose us

First received: November 22, 2022

Clinical Trial: A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Open-label, 52-week Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab (AMG 451) in Adolescent Subjects Aged ? 12 to < 18 Years With Moderate-to-severe Atopic Dermati

Brief Summary: The primary objective of this study is to describe the safety and tolerability of rocatinlimab in adolescents with moderate-to-severe AD.

Read more